BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Business

  Emergent Health Corp. Reports Further Progress

  November 30, 2009

   · 

  1 min read
• Business

  Sentinelle Medical and Siemens AG Collaborating on Solutions for Interventional Prostate MRI

  November 30, 2009

   · 

  3 min read
• Drug Development

  International AIDS Vaccine Initiative Release: Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses When the Vaccine is Delivered by Electrical Impulses

  November 30, 2009

   · 

  1 min read
• Genetown

  Three Lou Gehrig’s Disease (ALS) Organizations Grant Funding for Research Collaboration Between RXi Pharmaceuticals and University of Massachusetts Medical School

  November 30, 2009

   · 

  1 min read
• Drug Development

  Spectrum Pharmaceuticals, Inc. Announces Completion of Enrollment in One Apaziquone Phase 3 Pivotal Trial for Bladder Cancer Ahead of Schedule

  November 30, 2009

   · 

  1 min read
• PanGenex Corporation Provides Updated Time Line for Direct Response Television Program with Partner Incredible Discoveries(R) to Promote Scientifically Formulated, Condition Specific Dietary Supplements

  November 30, 2009

   · 

  1 min read
• Policy

  ChemGenex Pharmaceuticals Limited’s Marketing Authorization Application for Omacetaxine Mepesuccinate Validated by the European Medicines Evaluation Agency

  November 30, 2009

   · 

  1 min read
• Drug Development

  Novavax, Inc. Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults

  November 30, 2009

   · 

  5 min read
• FDA

  Boehringer Ingelheim Corporation Release: Major European Regulatory Milestone in Cardiovascular Protection for MICARDIS(R) (telmisartan): Now Approved by the European Commission (EC) to Reduce the Risk of Cardiovascular (CV) Morbidity in High CV Risk Pati

  November 30, 2009

   · 

  1 min read
• ApaTech Ltd is Europe’s Fastest Growing Lifescience Company

  November 30, 2009

   · 

  4 min read